AI reads prostate scans to predict survival

NCT ID NCT06363435

Recruiting now Knowledge-focused Sponsor: Elin Tragardh Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether an artificial intelligence (AI) system can automatically measure the amount of cancer seen on PSMA PET-CT scans in 1,500 men with prostate cancer. The AI will calculate tumor volume and uptake, and researchers will see if these measurements can predict how long patients live or when the cancer might come back. The AI results are not used to guide patient care during the study.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a reliable AI tool that helps doctors better predict outcomes for prostate cancer patients using standard scans.
What could go wrong: This is an observational study, not a treatment trial. The AI method is not yet proven to improve patient care, and results may not apply to all hospitals or scanners.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Skåne University Hospital
RECRUITING

Lund, Sweden
Skåne university hospital
RECRUITING

Malmö, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.